Rubric Capital Management LP - Q3 2023 holdings

$2.67 Billion is the total value of Rubric Capital Management LP's 61 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 37.1% .

 Value Shares↓ Weighting
IWM NewISHARES TRput$265,110,0001,500,000
+100.0%
9.94%
TEVA BuyTEVA PHARMACEUTICAL INDS LTDsponsored ads$193,800,000
+37.5%
19,000,000
+1.5%
7.27%
+20.6%
GLNG BuyGOLAR LNG LTD$157,853,925
+21.2%
6,506,757
+0.8%
5.92%
+6.3%
VTRS BuyVIATRIS INC$130,645,000
+9.5%
13,250,000
+10.9%
4.90%
-3.9%
BuyROIVANT SCIENCES LTD$122,640,000
+244.0%
10,500,000
+196.9%
4.60%
+201.8%
NewBGC GROUP INCcl a$105,600,00020,000,000
+100.0%
3.96%
COOP  MR COOPER GROUP INC$105,254,666
+5.8%
1,965,1730.0%3.95%
-7.2%
CCJ SellCAMECO CORP$100,033,126
+18.5%
2,523,540
-6.4%
3.75%
+3.9%
FLR SellFLUOR CORP NEW$87,333,412
-13.6%
2,379,657
-30.3%
3.28%
-24.2%
AIR  AAR CORP$73,127,962
+3.1%
1,228,4220.0%2.74%
-9.6%
COLL SellCOLLEGIUM PHARMACEUTICAL INC$70,961,250
-3.6%
3,175,000
-7.3%
2.66%
-15.4%
PARR SellPAR PAC HOLDINGS INC$70,880,185
-1.1%
1,972,181
-26.8%
2.66%
-13.3%
HTZZ SellHERTZ GLOBAL HLDGS INC$63,274,362
-39.9%
5,165,254
-9.7%
2.37%
-47.3%
SWM BuyMATIV HOLDINGS INC$57,040,000
+9.7%
4,000,000
+16.4%
2.14%
-3.7%
BuyRENEW ENERGY GLOBAL PLC$53,743,023
+20.1%
9,897,426
+21.2%
2.02%
+5.3%
KNSA SellKINIKSA PHARMACEUTICALS LTD$53,455,289
+12.4%
3,077,449
-8.9%
2.00%
-1.4%
NRG BuyNRG ENERGY INC$50,770,130
+97.4%
1,318,020
+91.6%
1.90%
+73.1%
BuyADEIA INC$49,555,296
-2.0%
4,640,009
+1.0%
1.86%
-14.0%
ANIP  ANI PHARMACEUTICALS INC$49,177,459
+7.9%
847,0110.0%1.84%
-5.4%
KOP BuyKOPPERS HOLDINGS INC$45,031,314
+23.9%
1,138,592
+6.9%
1.69%
+8.7%
OFIX BuyORTHOFIX MED INC$44,169,792
+2.2%
3,434,665
+43.6%
1.66%
-10.3%
BuyDOLE PLC$43,334,120
-11.9%
3,742,152
+2.9%
1.62%
-22.7%
BuyPACTIV EVERGREEN INC$40,650,000
+11.5%
5,000,000
+3.8%
1.52%
-2.2%
BuyXPERI INC$39,871,316
-21.1%
4,043,744
+5.2%
1.50%
-30.8%
HOLI  HOLLYSYS AUTOMATION TCHNGY L$38,514,142
+12.8%
1,941,2370.0%1.44%
-1.0%
TAC BuyTRANSALTA CORP$38,322,143
+19.5%
4,404,844
+28.6%
1.44%
+4.8%
PLYA SellPLAYA HOTELS & RESORTS NV$37,616,354
-35.9%
5,195,629
-27.9%
1.41%
-43.8%
CSTM SellCONSTELLIUM SE$35,567,787
-7.0%
1,954,274
-12.2%
1.33%
-18.5%
MGNI BuyMAGNITE INC$30,160,000
-0.2%
4,000,000
+80.7%
1.13%
-12.5%
HRTX BuyHERON THERAPEUTICS INC$27,514,908
+101.9%
26,713,503
+127.3%
1.03%
+77.0%
ARQT BuyARCUTIS BIOTHERAPEUTICS INC$26,733,354
-42.6%
5,034,530
+3.1%
1.00%
-49.6%
IMVT NewIMMUNOVANT INCput$21,874,622569,800
+100.0%
0.82%
NewQUIDELORTHO CORP$21,650,955296,426
+100.0%
0.81%
OVID  OVID THERAPEUTICS INC$20,912,294
+17.1%
5,445,9100.0%0.78%
+2.6%
VST SellVISTRA CORP$19,980,631
-72.9%
602,189
-78.6%
0.75%
-76.3%
SCPH BuySCPHARMACEUTICALS INC$19,318,603
+133.6%
2,713,287
+234.3%
0.72%
+104.8%
RVNC NewREVANCE THERAPEUTICS INC$18,352,0001,600,000
+100.0%
0.69%
AHCO SellADAPTHEALTH CORP$17,846,911
-49.1%
1,961,199
-31.9%
0.67%
-55.3%
AMRX BuyAMNEAL PHARMACEUTICALS INC$16,983,390
+110.6%
4,024,500
+54.7%
0.64%
+84.6%
BuyZYMEWORKS INC$16,809,838
-17.5%
2,651,394
+12.5%
0.63%
-27.6%
MREO  MEREO BIOPHARMA GROUP PLCspon ads$14,984,795
-2.3%
11,616,1200.0%0.56%
-14.3%
BuyOMNIAB INC$14,794,552
+319.0%
2,850,588
+306.0%
0.56%
+267.5%
MSGS NewMADISON SQUARE GRDN SPRT CORcl a$14,723,16683,512
+100.0%
0.55%
PCRX NewPACIRA BIOSCIENCES INC$14,101,663459,637
+100.0%
0.53%
SellTELESAT CORP$13,724,625
+15.0%
959,764
-24.3%
0.52%
+1.0%
SSYS NewSTRATASYS LTD$12,393,715910,633
+100.0%
0.46%
TRVI  TREVI THERAPEUTICS INC$12,392,036
-8.8%
5,684,4200.0%0.46%
-20.0%
STRO SellSUTRO BIOPHARMA INC$11,606,491
-38.4%
3,344,810
-17.4%
0.44%
-46.0%
CCO SellCLEAR CHANNEL OUTDOOR HLDGS$10,595,390
-55.5%
6,705,943
-61.4%
0.40%
-61.0%
 FTAI INFRASTRUCTURE INC$10,283,167
-12.7%
3,193,5300.0%0.39%
-23.4%
ARDX NewARDELYX INC$10,200,0002,500,000
+100.0%
0.38%
MX  MAGNACHIP SEMICONDUCTOR CORP$8,042,975
-25.7%
967,8670.0%0.30%
-34.8%
NewRISKIFIED LTD$7,213,9291,610,252
+100.0%
0.27%
MYPS  PLAYSTUDIOS INC$6,236,565
-35.2%
1,961,1840.0%0.23%
-43.2%
CGEM  CULLINAN ONCOLOGY INC$5,673,707
-15.9%
626,9290.0%0.21%
-26.0%
BCYC  BICYCLE THERAPEUTICS PLCsponsored ads$4,126,948
-21.3%
205,4230.0%0.16%
-30.8%
HOWL  WEREWOLF THERAPEUTICS INC$4,141,664
-29.8%
1,935,3570.0%0.16%
-38.5%
 THERAPEUTICSMD INC$3,600,417
-26.7%
1,192,1910.0%0.14%
-35.7%
CNDT NewCONDUENT INC$2,904,617834,660
+100.0%
0.11%
SBTX SellARS PHARMACEUTICALS INC$2,416,187
-87.1%
639,203
-77.2%
0.09%
-88.7%
VINC  VINCERX PHARMA INC$357,921
-22.3%
354,3770.0%0.01%
-35.0%
FREE ExitWHOLE EARTH BRANDS INC$0-70,985
-100.0%
-0.01%
KPTI ExitKARYOPHARM THERAPEUTICS INC$0-919,196
-100.0%
-0.07%
PNT ExitPOINT BIOPHARMA GLOBAL INC$0-190,000
-100.0%
-0.07%
SPCE ExitVIRGIN GALACTIC HOLDINGS INCput$0-600,000
-100.0%
-0.10%
PENN ExitPENN ENTERTAINMENT INC$0-137,428
-100.0%
-0.14%
ABUS ExitARBUTUS BIOPHARMA CORP$0-3,395,855
-100.0%
-0.33%
DMRC ExitDIGIMARC CORP NEW$0-375,353
-100.0%
-0.47%
ExitDIGITALBRIDGE GROUP INCcl a new$0-795,516
-100.0%
-0.50%
RDNT ExitRADNET INC$0-516,076
-100.0%
-0.72%
STNG ExitSCORPIO TANKERS INC$0-1,033,271
-100.0%
-2.09%
LC ExitLENDINGCLUB CORP$0-5,308,472
-100.0%
-2.21%
BGCP ExitBGC PARTNERS INCcl a$0-20,000,000
-100.0%
-3.79%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2023-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAGNACHIP SEMICONDUCTOR CORP28Q3 20234.7%
BGC PARTNERS INC20Q2 20234.6%
MR COOPER GROUP INC20Q3 20235.9%
PAR PACIFIC HOLDINGS INC18Q3 20233.9%
RADIUS HEALTH INC16Q2 20224.3%
CLEAR CHANNEL OUTDOOR HLDGS16Q3 20232.6%
HERON THERAPEUTICS INC15Q3 20239.0%
COLLEGIUM PHARMACEUTICAL INC15Q3 20233.9%
AAR CORP14Q3 20233.2%
GREEN PLAINS INC14Q3 20224.1%

View Rubric Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Rubric Capital Management LP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HERON THERAPEUTICS, INC. /DE/July 25, 202326,713,50319.0%
Amryt Pharma plcFebruary 10, 202318,000,0005.6%
BGC Partners, Inc.February 10, 202318,250,0005.6%
EverQuote, Inc.February 10, 20231,246,6224.8%
Ferroglobe PLCFebruary 10, 20233,232,7621.7%
Sio Gene Therapies Inc.February 10, 20237,000,0009.5%
Vincerx Pharma, Inc.February 10, 2023386,7191.8%
Whole Earth Brands, Inc.February 10, 2023998,3632.4%
Radius Health, Inc.June 16, 20226,959,30514.6%
ANTARES PHARMA, INC.February 14, 202210,800,0006.4%

View Rubric Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
PRRN14A2024-03-26
DFAN14A2024-03-11
PREC14A2024-03-08
SC 13D/A2024-02-21
SC 13D/A2024-02-14
13F-HR2024-02-13
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12

View Rubric Capital Management LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Rubric Capital Management LP's holdings